Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Insulin Lispro

Insulin Lispro

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Insulin Lispro

64 trials tracked of Insulin Lispro: 33 in phase 3 or 4 and 3 with published results. The most-cited published study has 131 citations.

64Trials tracked
33Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 11 Phase 3 22 Phase 2 5 Phase 1 24 Other / NA 2
  1. Phase 3 A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin Completed · 131 cited
  2. Phase 3 A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections Completed · 17 cited
  3. Phase 3 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Completed · 2 cited
  4. Phase 4 Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes Completed
  5. Phase 4 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Completed
  6. Phase 4 A Study on the Effect of 2 Pen Devices on HbA1c Completed
Show 44 more trials
  1. Phase 4 A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus Completed
  2. Phase 4 The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients Completed
  3. Phase 4 Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus Completed
  4. Phase 4 Comparison of Insulins Aspart and Lispro in Insulin Pumps Completed
  5. Phase 4 Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase Completed
  6. Phase 4 Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes Completed
  7. Phase 4 Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes Completed
  8. Phase 4 A Study for Type 2 Diabetic Patients Completed
  9. Phase 3 A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes Completed
  10. Phase 3 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes Completed
  11. Phase 3 A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy Completed
  12. Phase 3 A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus Completed
  13. Phase 3 A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes Completed
  14. Phase 3 A Study in Participants With Type 2 Diabetes Mellitus Completed
  15. Phase 3 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes Completed
  16. Phase 3 A Study of LY900014 in Participants With Type 1 Diabetes Completed
  17. Phase 3 A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Completed
  18. Phase 3 A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus Completed
  19. Phase 3 A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) Completed
  20. Phase 3 A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes Completed
  21. Phase 3 A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes Completed
  22. Phase 3 Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy Completed
  23. Phase 3 Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes Completed
  24. Phase 3 A Study in Participants With Type 1 Diabetes Mellitus Completed
  25. Phase 3 A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients Completed
  26. Phase 3 A Study in Participants With Type I Diabetes Mellitus Completed
  27. Phase 3 A Study in Adults With Type 1 Diabetes Completed
  28. Phase 2 A Study of LY900014 in a Medtronic Pump Completed
  29. Phase 2 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus Completed
  30. Phase 2 Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus Completed
  31. Phase 2 Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus Completed
  32. Phase 2 Feasibility Trial Testing the Bionic Pancreas With ZP4207 Completed
  33. Phase 1 A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants Completed
  34. Phase 1 A Study of LY900014 Formulations in Healthy Participants Completed
  35. Phase 1 A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump Completed
  36. Phase 1 Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone Completed
  37. Phase 1 A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy Completed
  38. Phase 1 A Study of LY900014 in Healthy Chinese Participants Completed
  39. Phase 1 A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus Completed
  40. Phase 1 A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy Completed
  41. Phase 1 A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus Completed
  42. Phase 1 A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus Completed
  43. Phase 1 A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone Completed
  44. Phase 1 A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM) Completed

Showing the 50 most-cited and recently-updated of 64 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.